Beone Medicines Ltd
(ONC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -644,786 | -881,708 | -2,003,815 | -1,457,816 | -1,600,523 |
| Depreciation Amortization | 171,762 | 87,675 | 66,278 | 46,457 | 31,789 |
| Income taxes - deferred | 25,983 | 689 | 2,059 | 3,377 | -27,807 |
| Accounts receivable | -329,443 | -188,306 | 304,112 | -423,019 | 10,363 |
| Accounts payable and accrued liabilities | 121,497 | 21,484 | -4,352 | 20,008 | 95,835 |
| Other Working Capital | -157,167 | -370,539 | 132,391 | -118,345 | 150,584 |
| Other Operating Activity | 671,523 | 173,252 | 6,708 | 630,615 | 56,298 |
| Operating Cash Flow | $-140,631 | $-1,157,453 | $-1,496,619 | $-1,298,723 | $-1,283,461 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,655 | 673,240 | 1,562,133 | 999,010 | N/A |
| PPE Investments | -492,663 | -561,896 | -325,434 | -262,942 | -117,508 |
| Purchase Of Investment | -19,006 | -14,900 | -15,911 | -43,500 | -26,681 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 2,751,075 |
| Purchase Sale Intangibles | -4,674 | -19,365 | N/A | -43,409 | N/A |
| Other Investing Activity | -39,336 | -36,440 | -143,665 | -51,909 | -5,775,252 |
| Investing Cash Flow | $-548,350 | $60,004 | $1,077,123 | $640,659 | $-3,168,366 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 868,270 | 661,530 | 313,774 | 406,449 | 323,697 |
| Debt Issued | 9,053 | 22,502 | 37,372 | 16,838 | 110,208 |
| Debt Repayment | -28,031 | -13,690 | N/A | N/A | -160,784 |
| Common Stock Issued | 45,373 | 55,712 | 46,964 | 3,535,378 | 4,325,118 |
| Other Financing Activity | -701,216 | -309,576 | -417,081 | -321,754 | 604,587 |
| Financing Cash Flow | $193,449 | $416,478 | $-18,971 | $3,636,911 | $5,202,826 |
| Exchange Rate Effect | -51,705 | -8,082 | -69,383 | 14,035 | 18,231 |
| Beginning Cash Position | 3,185,984 | 3,875,037 | 4,382,887 | 1,390,005 | 620,775 |
| End Cash Position | 2,638,747 | 3,185,984 | 3,875,037 | 4,382,887 | 1,390,005 |
| Net Cash Flow | $-547,237 | $-689,053 | $-507,850 | $2,992,882 | $769,230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -140,631 | -1,157,453 | -1,496,619 | -1,298,723 | -1,283,461 |
| Capital Expenditure | -492,663 | -561,896 | -325,434 | -262,942 | -117,508 |
| Free Cash Flow | -633,294 | -1,719,349 | -1,822,053 | -1,561,665 | -1,400,969 |